Cr yptococcus neoformans is encapsulated yeast that predominately infects immunocompromised individuals. Liver disease is an under-recognized predisposition for cryptococcal disease. We report two nonalcoholic, nondiabetic, and human immunodefi ciency virus -negative cirrhotic patients, with spontaneous cryptococcal peritonitis. Cryptococcus infection was diagnosed by culture of ascitic fl uid and peripheral blood in both. We treated the fi rst patient with amphotericin-B, but he expired. The second patient with earlier diagnosis, survived to discharge with fl uconazole treatment. We suggest a high clinical suspicion for Cryptococcus as a possible etiology of spontaneous peritonitis in cirrhotic patients.
Introduction
Cryptococcosis is the third most commonly occurring invasive fungal infection, after candidiasis and aspergillosis. Among human immunodeficiency negative (HIV) -negative patients, liver cirrhosis is an important risk factor for cryptococcal disease, with multiple case reports describing this association. However, liver disease as a predilection for cryptococcal disease is often under-appreciated, with resultant delay in diagnosis, and poor outcome.
We describe two patients with decompensated cirrhosis, and spontaneous fungal peritonitis due to Cryptococcus infection. Both patients were HIV negative, without any history of alcohol use, diabetes mellitus, or use of immunosuppressive drugs.
Case Reports

Case 1
A 65-year-old male was admitted to the hospital with complaints of progressive jaundice, weakness, and increasing ascites since 1 month. He was diagnosed as chronic hepatitis B-related cirrhosis, with virus-related fl are leading to hepatic decompensation. His Child-Pugh-Turcotte (CTP) and model of end stage liver disease (MELD) scores were 10 and 37, respectively.
His laboratory parameters at admission revealed, total white cell-count (total leukocyte count [ Figure 1 ]. Creamy white colonies were grown in culture [ Figure 2 ], which were identifi ed as C. neoformans by Biomerieux is a USA based diagnostic manufacturer of VITEK COMPACT SYSTEM-an automated system utilizing growth based technology, it accommodate colorimetric reagent cards (for yeast and yeast like organisms) that are incubated and interpreted automatically in yeast card; further susceptibility testing was also done in the antibiotic sensitivity card by the Vitek 2 Compact System. The isolate was sensitive to fl uconazole, fl ucytosine, amphotericin B and voriconazole.
T h e p a t i e n t w a s t r e a t e d w i t h amphotericin-B (AmBisome 50 mg/day) along with cefoperazone-sulbactam. We repeated ascitic fluid paracentesis was repeated twice, at 3 days intervals-similar cytological fi ndings were found without any decrease in the ascitic fl uid cell-count. The ascitic fl uid cultures and peripheral blood cultures repeatedly grew C. neoformans, despite amphotericin-B treatment. Bacterial cultures were negative. The urine cultures grew Candida tropicalis that persisted despite catheter change.
The patient developed lactic acidosis, and deteriorating renal function with anuria. The next-of-kin refused further interventions, and he died after 2 weeks of hospitalization. Postmortem liver biopsy showed cirrhosis, neutrophilic cholangiolitis, and cellular and canalicular cholestasis. No fungal elements were seen in the liver biopsy specimen.
Case 2
A 57-year-old male, with hepatitis C virus-related cirrhosis was admitted to the ICU with complaints of fever, pain abdomen, and increasing ascites. His CTP and MELD scores were 11 and 17, respectively.
His laboratory parameters at admission revealed, TLC: 7.85 × 10 3 cells/mm 3 , with 76% neutrophils, INR: 1.9, creatinine: 0.7 mg/dl, total bilirubin: 7.6 mg/dl (direct: 4.0 mg/dl), ALT: 55 U/L, ALP: 87 U/L, albumin: 1.6 g/dl, and ammonia: 120 mol/l. On computed tomographic study, cirrhotic liver with ascites, and small right pleural effusion with underlying consolidation was seen.
Abdominal paracentesis revealed slightly turbid ascitic fl uid, cell-count of 800/mm 3 , with predominantly lymphocytes, and albumin levels of 0.2 g/L. The patient was empirically treated with Ceftriaxone 1 g twice daily. Two days later, blood and ascitic fl uid culture grew C. neoformans, with similar sensitivity as in the fi rst case [ Figure 3 ]. There was no bacterial growth on peripheral blood culture. Repeat ascitic fl uid sample was sent after 2 days, which again grew the same fungal species. The patient was treated with intravenous fl uconazole 200 mg once daily, and Levofl oxacin 500 mg once daily for 7 days. The patient gradually improved and was discharged.
Discussion
Risk factors for disseminated cryptococcal disease are HIV infection, liver cirrhosis, lymphoid malignancies, corticosteroid treatment, and continuous ambulatory peritoneal dialysis (CAPD). [1] Cryptococcal peritonitis is considered uncommon and is seen mainly in patients with advanced cirrhosis, and those on CAPD. In older series, peritonitis accounted for < 5% of all cryptococcosis cases in HIV-negative patients, although these are probably underestimates. [2] Leukocyte functional impairment, complement dysfunction, and decreased opsonin activity are believed to predispose cirrhotic patients to cryptococcosis.
When should we suspect fungal peritonitis? The symptoms and signs of cryptococcal peritonitis are nonspecific. However, negative bacterial cultures, prolonged course of infection, recent antibiotic use, and history of previous ascitic fl uid sampling may be useful clues. The ascitic fl uid can be mildly turbid or even bloody. Most reports describe a modest ascitic fl uid cell-count with lymphocytic predominance, although neutrophilic dominance is also reported. While ascitic fluid lymphocytosis may reflect previous antibiotic use, persistent high cell-count despite appropriate antibiotics may be an important pointer to cryptococcal etiology. Our fi rst patient did not show any reduction in his ascitic fl uid cell-count, and the second showed a delayed response.
In suspected cryptococcal peritonitis, frequent abdominal paracentesis with bedside inoculations of fungal culture medium, India ink preparations, and serum and/or ascitic fl uid cryptococcal antigen testing by latex agglutination or enzyme immunoassay may establish the diagnosis. Serum cryptococcal antigen titers are also a marker of response to therapy in disseminated cryptococcosis. However, no such data for serial ascitic fl uid antigen titers exist, in cryptococcal peritonitis. Cryptococcus can be identifi ed on cytology as yeast-like encapsulated organisms with Mucicarmine and periodic acid-Schiff positive capsule, which can be highlighted by use of India ink stain. A rapid diagnosis can be made with cytological smears of ascitic fl uid, provided the suspicion for this infection is conveyed to the laboratory. [3] Species determination requires culture. [3, 4] All patients with suspected or documented cryptococcosis should have blood and urine fungal cultures, bronchoalveolar lavage if pulmonary infi ltrates are present, and a lumbar puncture for cerebrospinal fl uid (CSF) examination in cases with altered mentation. Cryptococcus can be isolated from the blood in some cases of cryptococcal peritonitis. Similar to the present report, Jean et al., described fungemia in two cases with primary C. neoformans peritonitis. [5] We did not fi nd Cryptococcus organisms in the liver biopsy of the patient who succumbed, possibly because we did not use special stains to highlight the fungal elements. In a patient with postcardiac transplant HBV re-activation, cryptococci were demonstrated in dilated sinusoids in the liver biopsy, as groups of bright, rounded, colorless cells with a central nucleus, staining with Periodic acid-Schiff stain. [6] Cryptococcus can also directly infect the liver parenchyma, and there are reports of cryptococcal liver abscess, [7] necrotizing hepatitis, [8] and liver dysfunction in both immunocompromised and immunocompetent patients. [9] [10] [11] A m o n g b o t h i m m u n o c o m p r o m i s e d a n d immunocompetent patients, the most common clinical manifestation of cryptococcal infection is meningo-encephalitis.
[2] CSF examination is often not possible due to coexisting coagulopathy in patients with decompensated cirrhosis, as in our patients. Altered mentation in cirrhotic patients with cryptococcal meningo-encephalitis may be attributed to hepatic encephalopathy, and imaging of the brain is usually normal. A high index of suspicion is needed in cirrhotic patients with poorly resolving or prolonged peritonitis for coexisting cryptococcal meningitis.
Prognosis for disseminated cryptococcosis and liver cirrhosis is poor. In a large review of 33 patients with cryptococcal peritonitis, Singh et al. have reported a high mortality rate of 81%. [12] Chuang et al. have reported that all 12 HIV-negative patients, with cirrhosis and disseminated cryptococcosis died. [13] Jean et al. have reported that liver cirrhosis was a strong independent predictor of 30 days mortality with disseminated cryptococcosis, with an adjusted hazard ratio of 16.3. [14] Our fi rst patient died in spite of appropriate anti-fungal drugs.
The tropical climate of the Indian subcontinent offers a suitable environment for C. neoformans. There is widespread environmental prevalence of Cryptococcus species in India, and many reports of neurological infections in patients with and without HIV infection. However, there are only two previous reports of cryptococcal infection in patients with cirrhosis from this country, describing spontaneous cryptococcal peritonitis in two patients, [15] and pleural fl uid infection in one patient with decompensated cirrhosis. [16] It is likely that cryptococcal peritonitis is an under-reported infection among patients with cirrhosis.
Lymphocytic ascitic fluid also should suggest tuberculosis/fungal and metastatic malignancy and these should typically be evaluated for in patients with high cell-counts with lymphocytic predominance.
